Northsight Capital Appoints Pharmaceutical and Biotech Sales Industry Veteran John B. Hollister as Chief Executive Officer

(Hollister is one of the few executives in the cannabis space who have successfully completed a major funding)

As a Director and Global Commercial Leader in Oncology at Amgen, Hollister was responsible for leading several multidisciplinary teams developing oncology molecules, as well as phase IV management of Neulasta. He has a strong working knowledge of all facets of product development and commercialization. Hollister was CEO and Chairman of medical device company EGG Spectrum International, and Senior VP for a diagnostic company, Tethys Bioscience. In addition, Hollister is a long-standing board member for the leading charity in mental health research, the Brain and Behavior Research Foundation. Hollister received his undergraduate degree in Economics from Stanford University and his MBA from the Drucker School of Management at the Claremont Graduate University.

Hollister stated: “With the rapidly evolving view of medical and personal use of marijuana, comes a tremendous need for access to...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.